Is stem cell therapy legal in Korea?

Is stem cell therapy legal in Korea? The short answer

Is stem cell therapy legal in Korea? Yes, when it follows the law, and no, when it does not. Korea is one of the countries that has built a formal legal framework for regenerative medicine, rather than leaving it unregulated. That framework sets out who may provide cell-based treatments, for which patients, and with what oversight.

This page is a general guide for patients, not legal advice. Regulations change and their detail matters, so we encourage you to verify the current position with official sources and to ask any provider for documents showing the approval behind a proposed treatment.

The Advanced Regenerative Bio Act

Korea's Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biological Products, usually called the Advanced Regenerative Bio Act, regulates regenerative medicine, including cell therapies. For several years after it took effect in 2020, treatment under the Act was largely limited to approved clinical research.

An amendment that took effect in February 2025 widened this. It allows regenerative treatments to be provided to patients, not only research participants, at designated regenerative medical institutions, under treatment plans reviewed and approved through the official review process. The framework focuses on patients with serious, rare or hard-to-treat conditions, and approved plans come with safety monitoring and reporting duties.

In practice, this means the question is rarely simply whether stem cells are allowed. It is whether this particular treatment, at this particular institution, for this particular patient, sits within an approved pathway.

MFDS-approved cell therapy products

Separately, the Ministry of Food and Drug Safety (MFDS) approves cell therapy products in much the same way it approves medicines. A number of cell therapy products, including some stem cell-based products, have been approved in Korea for specific indications. Approval applies to that product, for that indication, used as directed. It does not make every stem cell treatment lawful or proven for other uses.

If a clinic names an approved product, you can ask what indication it is approved for and whether your condition matches it.

Approved products are typically used in hospital settings for the conditions they were approved for, under the prescribing rules that come with approval. A wellness or anti-aging use outside those indications is a different matter and should be discussed openly.

Questions to ask any clinic

A legitimate provider should answer clearly and in writing. If the answers are vague, take that as a warning sign.

Useful official starting points include the Ministry of Food and Drug Safety for approved products and the Ministry of Health and Welfare for the regenerative medicine framework. If you are unsure how to read a document, bring it to your consultation or ask your own specialist to look at it with you.

Remember too that the law in your home country may differ. If you plan to continue care or follow-up at home, check that your doctor there is willing to monitor you after a treatment received in Korea.

• Which legal pathway does this treatment use: an approved product, an approved plan under the Advanced Regenerative Bio Act, or something else?
• Is this clinic or its partner hospital a designated regenerative medical institution, if that is required?
• Can you show the approval or plan details in writing?
• Where are the cells processed, and is that facility licensed?
• What evidence supports this treatment for my specific condition, and what are the known risks?
• How will side effects be monitored and reported after treatment?

Limits, risks and when to say no

Legal status is not the same as proof of benefit. Many uses of stem cells remain experimental, and results vary between individuals. Risks include infection, injection-site pain, immune reactions and, with unregulated or poorly processed products, serious complications. If you develop fever, spreading redness, severe pain or breathing difficulty after any procedure, seek urgent care; in Korea, call 119.

Be cautious of any treatment offered as a cure, marketed for many unrelated conditions, or provided without a clear explanation of its legal basis. Do not stop treatment prescribed by your specialist in favor of a stem cell procedure.

At VEI Clinic, stem cell programs are consultation-based. Dr. HyunSung Park, an internal medicine specialist and ISSCR member, assesses suitability individually and explains the regulatory status of any option discussed; he does not promise outcomes.